Testing effectiveness (Phase 2)Ended earlyNCT01757197
What this trial is testing
Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)
Who this might be right for
Glucocorticosteroid Refractory Acute GVHD
Weill Medical College of Cornell University 2